GnuBio Starts Early-Access Testing of Instrument at Montreal Heart Institute
July 19, 2011
GnuBio Starts Early-Access Testing of Instrument at Montreal Heart Institute
Researchers at the institute have already used the system to sequence the TNNT2 gene in a number of clinical samples from a French Canadian cohort.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Montreal Heart Institute Developing GnuBio Sequencing Panel for Sudden Cardiac Death Test
February 1, 2012 / Pharmacogenomics Reporter - GnuBio Claims Proof of Principle for Sequencing; Plans to Ship Early Commercial Systems by Year-End
April 12, 2011 / In Sequence - Antibody Firm Affomix to Collaborate with U of Montreal's PGx Centre on Heart Disease Biomarkers
June 4, 2010 / ProteoMonitor - Montreal Heart Institute Developing Cardiac Screening Panel for GnuBio Sequencer
January 11, 2012 / GenomeWeb Daily News - GnuBio Targets 1K-Base Reads for Commercial Launch of $50K Sequencer
October 4, 2011 / In Sequence